These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 8643444

  • 21. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
    Ito T, Uchida K, Nakayama H.
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
    [Abstract] [Full Text] [Related]

  • 22. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T, Muramatsu Y, Tanaka K, Matsubara M, Imai Y.
    Neurosci Lett; 2001 Oct 12; 312(1):50-4. PubMed ID: 11578843
    [Abstract] [Full Text] [Related]

  • 23. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T.
    Neuropharmacology; 2006 Mar 12; 50(3):329-44. PubMed ID: 16303147
    [Abstract] [Full Text] [Related]

  • 24. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 25. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY, Jang EH, Park CS, Kang JH.
    Free Radic Biol Med; 2005 Mar 15; 38(6):806-16. PubMed ID: 15721991
    [Abstract] [Full Text] [Related]

  • 26. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
    Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE, Chung WG.
    Neurotoxicology; 2002 Sep 15; 23(3):367-74. PubMed ID: 12387363
    [Abstract] [Full Text] [Related]

  • 27. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 15; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 28. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P, Ferger B.
    Neuroscience; 2016 Nov 19; 337():218-223. PubMed ID: 27651149
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL.
    Neurotoxicology; 2013 Jul 19; 37():1-14. PubMed ID: 23523781
    [Abstract] [Full Text] [Related]

  • 30. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
    Bezard E, Jaber M, Gonon F, Boireau A, Bloch B, Gross CE.
    Eur J Neurosci; 2000 Aug 19; 12(8):2892-900. PubMed ID: 10971632
    [Abstract] [Full Text] [Related]

  • 31. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J, Graham DG, Montine TJ, Ho YS.
    J Neuropathol Exp Neurol; 2000 Jan 19; 59(1):53-61. PubMed ID: 10744035
    [Abstract] [Full Text] [Related]

  • 32. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K, Miller DB, O'Callaghan JP.
    J Neurochem; 2006 Feb 19; 96(3):706-18. PubMed ID: 16405514
    [Abstract] [Full Text] [Related]

  • 33. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    Nature; 2006 Feb 19; 311(5985):467-9. PubMed ID: 6332989
    [Abstract] [Full Text] [Related]

  • 34. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
    Gao L, Díaz-Martín J, Dillmann WH, López-Barneo J.
    Neuroscience; 2011 Oct 13; 193():323-9. PubMed ID: 21782904
    [Abstract] [Full Text] [Related]

  • 35. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 13; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 36. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW.
    Brain Res; 1987 Feb 10; 403(1):43-51. PubMed ID: 3493827
    [Abstract] [Full Text] [Related]

  • 37. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S.
    Nat Med; 1999 Dec 10; 5(12):1403-9. PubMed ID: 10581083
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
    Di Monte DA, Royland JE, Anderson A, Castagnoli K, Castagnoli N, Langston JW.
    J Neurochem; 1997 Oct 10; 69(4):1771-3. PubMed ID: 9326308
    [Abstract] [Full Text] [Related]

  • 39. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM.
    Proc Natl Acad Sci U S A; 2001 Dec 04; 98(25):14669-74. PubMed ID: 11724929
    [Abstract] [Full Text] [Related]

  • 40. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
    Oeckl P, Scheffold A, Lechel A, Rudolph KL, Ferger B.
    Neuroreport; 2014 Mar 26; 25(5):335-9. PubMed ID: 24525820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.